Viewing nowCombinationTelowjeong 80/10 milligrams
Telmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Korea Union Pharm Co., Ltd.

MFDS item code 202001851 · Approved 2020.03.17
Treatment of hypertension and dyslipidemia, reduction of cardiovascular disease risk, and suppression of atherosclerosis progression
This medication is used for patients who require co-administration of the two drugs Telmisartan and Rosuvastatin. Telmisartan is effective in reducing the risk of myocardial infarction, stroke, and mortality in patients with essential hypertension and those at high risk for cardiovascular disease. Rosuvastatin is used as an adjunct to diet in patients with hypercholesterolemia and dyslipidemia, lowering total cholesterol and LDL cholesterol levels, thus delaying the progression of atherosclerosis. Additionally, it helps reduce the risk of stroke, myocardial infarction, and arterial revascularization in high-risk groups with chronic cardiovascular disease. By using these two drugs together, it effectively manages hypertension and hyperlipidemia, reducing the risk of cardiovascular diseases.
This medicine should be administered only to adults. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan and rosuvastatin components. ○ Telmisartan 1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to up to 80 mg once daily. When this medicine is coadministered with a thiazide diuretic, such as hydrochlorothiazide, an additional blood pressure-lowering effect is observed. When increasing the dose, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after the start of treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose of this medicine is 80 mg orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. 3. Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin calcium 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, the treatment goal, and the patient's response; it may be increased to a maximum of 20 milligrams once daily. 2. Elderly patients: No dosage adjustment is necessary. 3. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine at a dose of 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients. Patients taking telmisartan and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience of administration.
This medication can cause serious harm, especially to the fetus and newborn during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. This medicine should not be taken by individuals who are allergic to this medication or its components, by women who are pregnant or may become pregnant, or by nursing mothers. Patients with severely impaired liver function or problems with bile secretion should avoid using this medication. Patients with muscle disorders or those who have previously experienced muscle-related side effects should also avoid taking this medication. Patients with significantly reduced kidney function or those taking certain immunosuppressants should not use this medication. This medication contains lactose; thus, patients with lactose intolerance or related genetic disorders should avoid it. Elderly patients, those with high potassium levels, and patients with mildly impaired liver function should be cautious when taking this medication. This medication can cause myalgia, myopathy, and rarely severe muscle destruction known as rhabdomyolysis; therefore, if any abnormal muscle symptoms occur, immediate consultation with a physician is needed. Regular liver function and muscle enzyme tests should be conducted; if abnormalities are found, discontinuation may be warranted. This medication may interact with other antihypertensive medications or lipid-lowering agents, so it is essential to inform the doctor of any other medications being taken. Care should be taken while driving or operating machinery, as dizziness or drowsiness may occur.
Headache, postural dizziness, hypersomnia, increased blood pressure, decreased blood pressure, hypotension, elevated ALT, dysuria, rhinitis, discomfort in oropharynx, pulmonary disease, unspecified gastrointestinal disease, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory loss, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, halitosis, fatty liver, upper respiratory infection, urinary tract infection, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbance, dizziness, bradycardia, tachycardia, dyspnea, abdominal pain, diarrhea, indigestion, abdominal distension, vomiting, abdominal discomfort, dry mouth, liver function abnormalities, liver disorder, increased sweating, itching, rash, erythema, angioedema, drug rash, toxic skin rash, eczema, urticaria, myalgia, low back pain, muscle cramps, arthralgia, limb pain, tendon pain, acute kidney failure, chest pain, fatigue, influenza-like illness, increased serum creatinine, increased serum uric acid, increased liver enzymes, elevated serum CK, decreased hemoglobin, decreased libido, facial spasms, sensory abnormalities, paralysis, cough, hyperventilation, pneumonia, flushing, erectile dysfunction, loss of appetite, edema, facial swelling, alopecia, conjunctivitis, tinnitus, petechiae, palpitations, fatigue, nausea, ineffectiveness, hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, pancreatitis, pruritus, rash, urticaria, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, diarrhea, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, myasthenia gravis, ocular myasthenia gravis, hypotension, tachycardia, bradycardia, acute kidney failure, hypoglycemia, weakness, hunger, cold sweat, hand tremors, decreased concentration, convulsions, altered consciousness, angioedema, laryngeal edema, shock, loss of consciousness, liver dysfunction, jaundice, anaphylactic-like symptoms, interstitial pneumonia, rhabdomyolysis, palpitations, fatigue, nausea, ineffectiveness, headache, facial spasms, sensory abnormalities, paralysis, cough, hyperventilation, pneumonia, flushing, erectile dysfunction, loss of appetite, edema, facial swelling, rash, alopecia, conjunctivitis, tinnitus, petechiae, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, myasthenia gravis, ocular myasthenia gravis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage will help maintain the efficacy of the medication for a longer period.
Bright blue oval film-coated tablet
30 tablets/box[(10 tablets/PTP*3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Korea Union Pharm Co., Ltd.
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhannanghang Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhan Corporation Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.